Compugroup Medical SE (ETR:COP) has been given an average rating of “Hold” by the six analysts that are presently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is €68.17 ($76.59).
COP has been the subject of a number of recent research reports. Baader Bank set a €67.00 ($75.28) price target on shares of Compugroup Medical and gave the stock a “sell” rating in a research note on Wednesday, May 13th. Berenberg Bank set a €75.00 ($84.27) price target on shares of Compugroup Medical and gave the stock a “neutral” rating in a research note on Tuesday, June 2nd. Finally, Warburg Research set a €80.00 ($89.89) price target on shares of Compugroup Medical and gave the stock a “buy” rating in a research note on Thursday, May 7th.
Shares of Compugroup Medical stock traded down €0.20 ($0.22) during trading hours on Friday, hitting €64.10 ($72.02). The company had a trading volume of 209,933 shares, compared to its average volume of 68,245. The company’s 50-day moving average is €70.56 and its two-hundred day moving average is €64.26. Compugroup Medical has a twelve month low of €46.46 ($52.20) and a twelve month high of €78.50 ($88.20). The company has a debt-to-equity ratio of 177.81, a current ratio of 0.99 and a quick ratio of 0.78. The company has a market cap of $3.20 billion and a P/E ratio of 54.32.
CompuGroup Medical Societas Europaea develops and sells software and information technology services for healthcare sector worldwide. The company's Ambulatory Information Systems segment provides practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician's networks.
Recommended Story: Intrinsic Value
Receive News & Ratings for Compugroup Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical and related companies with MarketBeat.com's FREE daily email newsletter.